(Q53305334)

13 May 2018

title

Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus. (English)

1 reference

13 May 2018

author

Harald Sommer

10

0 references

author name string

Wolfgang Janni

1

1 reference

13 May 2018

Florian Hepp

2

1 reference

13 May 2018

Barbara Strobl

3

1 reference

13 May 2018

Brigitte Rack

4

1 reference

13 May 2018

Dorothea Rjosk

5

1 reference

13 May 2018

Christina Kentenich

6

1 reference

13 May 2018

Christian Schindlbeck

7

1 reference

13 May 2018

Peer Hantschmann

8

1 reference

13 May 2018

Klaus Pantel

9

1 reference

13 May 2018

Stephan Braun

11

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 January 2003

1 reference

13 May 2018

published in

Cancer

1 reference

13 May 2018

volume

97

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

page(s)

405-411

1 reference

13 May 2018

[Adjuvant radio- and chemotherapy in cervix carcinoma]

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Induction and rejoining of DNA double-strand breaks in human cervix carcinoma cell lines of differing radiosensitivity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Effect of cisplatin on the clinically relevant radiosensitivity of human cervical carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Bone metastasis from cervix cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Bone metastasis from gynecologic carcinomas: a clinicopathologic study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Occult tumor cells in bone marrow of patients with locoregionally restricted ovarian cancer predict early distant metastatic relapse.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Prognostic significance of bone marrow micrometastases in patients with gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Detection and characterization of residual disease in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 Workshop.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Microenvironment revisited: time for reappraisal of some prevailing concepts of cancer metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Micrometastases and survival in stage II colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Molecular quantification and mapping of lymph-node micrometastases in cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Cytokeratin-immunoreactive cells of human lymph nodes and spleen in normal and pathological conditions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Expression of MUC-1 epitopes on normal bone marrow: implications for the detection of micrometastatic tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Cytokeratin expression in squamous metaplasia of the human uterine cervix

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Cytokeratin 10/13, 14, 7, 8, and 18 in invasive squamous cell carcinoma and adenocarcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Prognostic significance of serum fragments of cytokeratin 19 measured by Cyfra 21-1 in cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Serum levels of cytokeratin 19 fragments in cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Expression of cytokeratin 10, 13, and involucrin as prognostic factors in low stage squamous cell carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Schauta-Amreich vaginal hysterectomy and Wertheim-Meigs abdominal hysterectomy in the treatment of cervical cancer: a retrospective analysis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11066

7 January 2021

Identifiers

DOI

10.1002/CNCR.11066

1 reference

13 May 2018

1 reference

13 May 2018